Cellebrite DI Lowers FY2026 Sales Guidance from $555.000M-$561.000M to $553.000M-$558.000M vs $556.733M Est
Benzinga Newsdesk 8 hours ago
NewsGuidance
Cellebrite DI (NASDAQ:CLBT) lowers FY2026 sales outlook from $555.000 million-$561.000 million to $553.000 million-$558.000 million vs $556.733 million estimate.
Cellebrite DI (NASDAQ:CLBT) lowers FY2026 sales outlook from $555.000 million-$561.000 million to $553.000 million-$558.000 million vs $556.733 million estimate.